Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Aprepitant Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102382780B reveals a novel Microbacterium oxydans strain for high-purity chiral alcohol production, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN105085189A details a robust aprotic solvent method for chiral alcohol synthesis, offering significant supply chain stability and cost reduction for pharmaceutical intermediates.
Patent CN111004190A reveals a robust Suzuki coupling route for aprepitant intermediates, offering safer scale-up and cost reduction in API manufacturing.
Patent CN112624901B details a novel refining method for chiral alcohols using polymer-supported catalysts and specific ether solvents, ensuring >99% purity for API manufacturing.
Novel biomimetic catalytic transfer hydrogenation for aprepitant intermediates. High yield, mild conditions, cost-effective manufacturing solution.
Patent CN112174909B details a green method for aprepitant intermediates using biomimetic catalysts, offering high purity and scalability for pharma supply chains.
Novel hydrolysis method for high-purity morpholinone intermediates. Reduces cost and improves yield for aprepitant synthesis. Reliable supply chain partner.